Terlipressin and gelafundin: Safe therapy of hepatorenal syndrome

European Journal of Medical Research

Volumn 9, Issue 2, 2004, Pages 78-82

  Saner, F H ^a   Kavuk, I ^a   Laing, H ^a   Biglarnia, R ^a   Fruhauf N R ^a   Schafers R F ^a   Malago M ^a   Broelsch, C E ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Hepatorenal syndrome; Liver failure; Terlipressin; Transplantation

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; DRUG DERIVATIVE; GELATIN; LYPRESSIN; PLASMA SUBSTITUTE; TERLIPRESSIN;

ARTICLE; BLOOD; CLINICAL TRIAL; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HEPATORENAL SYNDROME; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; PILOT STUDY; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; CREATININE; GELATIN; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HEPATORENAL SYNDROME; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY FUNCTION TESTS; LYSINE VASOPRESSIN; PILOT PROJECTS; PLASMA SUBSTITUTES; TREATMENT OUTCOME;

EID: 5444271322     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Arroyo V, Gines P, Gerbes AL, et al. (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 21 164-176
2. Cittanova, M. L., Leblanc, I., Legendre, C., et al. (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348: 1620-1622
3. Dietrich HJ (2001) Kolloide in der Intensivmedizin. Anaesthesist 50: 54-68
4. Fachinformation (1996) Glycylpressin R, Terlipressin Acetate.Kiel: Ferring Arzneimittel GmbH 1996
5. Foley EF, Borlase BC, Dzik WH, et al. (1990) Albumin supplementation in the critically ill. A prospective, randomized trial. Arch Surg 125: 739-742
6. Forsling ML, Aziz LA, Miller M, et al. (1980) Conversion of triglycylvasopressin to lysine-vasopressin in man. J Endocrinol 85: 237-244
7. Ganne-Carrie N, Hadengue A, Mathurin P, et al. (1996) Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation. Dig Dis Sci 41: 1054-1056
8. Gines A, Escorsell A, Gines P, et al. (1993) Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105: 229-236
9. Gines P, Arroyo V (1999)-Hepatorenal syndrome. J Am Soc Nephrol 10: 1833-1839
10. Golub R, Sorrento JJ Jr., Cantu R Jr, et al. (1994) Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized study. Crit Care Med 22: 613-619
11. Gonwa T A, Goldstein M, Holman M, et al. (1993) Orthotopic liver transplantation and renal function; outcome of hepatorenal syndrome and trial of verapamil for renal protection in nonhepatorenal syndrome. Transplant Proc 25: 1891-1892
12. Guevara M, Gines P, Fernandez-Esparrach G, et al. (1998) Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27: 35-41
13. Gulberg V, Bilzer M, Gerbes AL (1999) Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology 30: 870-875
14. Hadengue A, Gadano A, Moreau R, et al. (1998) Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 29: 565-570
15. Kumle B, Boldt J, Piper S, et al. (1999) The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg 89: 1124-1130
16. Le Moine O, el Nawar A, Jagodzinski R, et al. (1998) Treatment with terlipressin as a bridge to liver transplantation in a patient with hepatorenal syndrome. Acta Gastroenterol Belg 61: 268-270
17. McCloy RM, Baldus WP, Tauxe WN, et al. (1967) Plasma volume and renal circulatory function in cirrhosis. Ann Intern Med 66: 307-311
18. Medel J, Boccara G, Van de Steen E, et al. (2001) Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg 93: 53-55, TOC
19. Ortega R, Gines P, Uriz J, et al. (2002) Terlipressin therapy with arid without albumin for patients with hepatorenal syndrome: results of a prospective, non-randomized study. Hepatology 36: 941-948
20. Peron S, Mouthon L, Guettier C, et al. (2001) Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol 55: 408-411
21. Reviewers CIGA (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Bmj 317: 235-240
22. Rimola A, Gavaler JS, Schade RR, et al. (1987) Effects of renal impairment on liver transplantation. Gastroenterology 93: 148-156
23. Saner FH, Fruhauf NR, Schafers RF, et al. (2003 Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome. Eur J Gastroenterol Hepatol 15: 925-927
24. Schrier RW, Niederberger M, Weigert A, et al. (1994) Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis. Semin Liver Dis 14: 14-22
25. Solanki P, Chawla A, Garg R, et al. (2003) Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 18: 152-156
26. Tullis JL (1977) Albumin. 2. Guidelines for clinical use. Jama 237: 460-463 concl.
27. Uriz J, Gines P, Cardenas A, et al. (2000) Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 33: 43-48